Agfa-Gevaert (ENXTBR:AGFB) - Share price, News & Analysis

AGFB fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

AGFB Stock Overview

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide.

Rewards

Trading at 63.3% below our estimate of its fair value

Risk Analysis

Earnings have declined by 48.1% per year over past 5 years

Agfa-Gevaert Competitors

International Business Machines

NYSE:IBM

US$119.6b

Siemens

XTRA:SIE

€89.8b

General Electric

NYSE:GE

US$82.8b

Hitachi

TSE:6501

JP¥6.3t

Price History & Performance

Summary of all time highs, changes and price drops for Agfa-Gevaert
Historical stock prices
Current Share Price	€3.71
52 Week High	€4.59
52 Week Low	€2.92
Beta	0.68
1 Month Change	-4.26%
3 Month Change	3.34%
1 Year Change	-2.37%
3 Year Change	-1.49%
5 Year Change	-11.01%
Change since IPO	-82.71%

Shareholder Returns

	AGFB	BE Healthcare Services	BE Market
7D	4.8%	5.9%	-1.3%
1Y	-2.4%	-20.7%	-4.5%

Return vs Industry: AGFB exceeded the Belgian Healthcare Services industry which returned -20.2% over the past year.

Return vs Market: AGFB underperformed the Belgian Market which returned -1.4% over the past year.

Price Volatility

Is AGFB's price volatile compared to industry and market?
AGFB volatility
AGFB Average Weekly Movement	5.3%
Healthcare Services Industry Average Movement	7.5%
Market Average Movement	5.2%
10% most volatile stocks in BE Market	7.9%
10% least volatile stocks in BE Market	3.1%

Stable Share Price: AGFB is not significantly more volatile than the rest of Belgian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: AGFB's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1867	7,108	Pascal Juery	https://www.agfa.com

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. The company’s Offset Solutions segment provides commercial, newspaper, and packaging printers; integrated prepress and printing solutions, including computer-to-plate systems using digital offset printing plates, pressroom supplies, and software for workflow optimization, color management, screening, and print standardization; and security printing software solutions. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software.

Agfa-Gevaert Fundamentals Summary

How do Agfa-Gevaert's earnings and revenue compare to its market cap?
AGFB fundamental statistics
Market Cap	€580.17m
Earnings (TTM)	-€16.00m
Revenue (TTM)	€1.79b

0.3x

P/S Ratio

-36.3x

P/E Ratio

Is AGFB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
AGFB income statement (TTM)
Revenue	€1.79b
Cost of Revenue	€1.29b
Gross Profit	€503.00m
Other Expenses	€519.00m
Earnings	-€16.00m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 24, 2022

Earnings per share (EPS)	-0.10
Gross Margin	28.13%
Net Profit Margin	-0.89%
Debt/Equity Ratio	10.0%

How did AGFB perform over the long term?

See historical performance and comparison

Valuation

Is Agfa-Gevaert undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: AGFB (€3.71) is trading below our estimate of fair value (€10.11)

Significantly Below Fair Value: AGFB is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: AGFB is unprofitable, so we can't compare its PE Ratio to the European Healthcare Services industry average.

PE vs Market: AGFB is unprofitable, so we can't compare its PE Ratio to the Belgian market.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AGFB's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: AGFB is good value based on its PB Ratio (0.9x) compared to the XE Healthcare Services industry average (2.8x).

Future Growth

How is Agfa-Gevaert forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

-3.3%

Forecasted annual revenue growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AGFB's forecast earnings growth is above the savings rate (1.1%).

Earnings vs Market: Insufficient data to determine if AGFB's earnings are forecast to grow faster than the Belgian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AGFB's revenue is expected to decline over the next 3 years (-3.3% per year).

High Growth Revenue: AGFB's revenue is forecast to decline over the next 3 years (-3.3% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AGFB's Return on Equity is forecast to be high in 3 years time

Past Performance

How has Agfa-Gevaert performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

-48.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AGFB is currently unprofitable.

Growing Profit Margin: AGFB is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: AGFB is unprofitable, and losses have increased over the past 5 years at a rate of 48.1% per year.

Accelerating Growth: Unable to compare AGFB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AGFB is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-3%).

Return on Equity

High ROE: AGFB has a negative Return on Equity (-2.06%), as it is currently unprofitable.

Financial Health

How is Agfa-Gevaert's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: AGFB's short term assets (€1.4B) exceed its short term liabilities (€630.0M).

Long Term Liabilities: AGFB's short term assets (€1.4B) exceed its long term liabilities (€804.0M).

Debt to Equity History and Analysis

Debt Level: AGFB has more cash than its total debt.

Reducing Debt: AGFB's debt to equity ratio has reduced from 37.3% to 10% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AGFB has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AGFB has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

Dividend

What is Agfa-Gevaert current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate AGFB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AGFB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AGFB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AGFB's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as AGFB has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.1yrs

Average management tenure

CEO

Pascal Juery (56 yo)

2.25yrs

Tenure

€1,179,000

Compensation

Mr. Pascal Juéry serves as Chief Executive Officer at Agfa-Gevaert NV since February 1, 2020 and also serves as its President since 2020. Mr. Juéry serves as a Director of Agfa-Gevaert NV since 2020 and al...

CEO Compensation Analysis

Compensation vs Market: Pascal's total compensation ($USD1.25M) is above average for companies of similar size in the Belgian market ($USD802.79K).

Compensation vs Earnings: Pascal's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: AGFB's management team is considered experienced (3.1 years average tenure).

Board Members

Experienced Board: AGFB's board of directors are considered experienced (3.3 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/19 00:00
End of Day Share Price	2022/05/19 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31